aluates Reports

$ 0.0

Automative

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-30S5640

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-30S5640

Report

June 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Yin Feng Gene

KingMed

Geneis

Haplox

Amoydx

Admera

GeneChem

Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastrointestinal Stromal Tumor Molecular Diagnostics Market

The global market for Gastrointestinal Stromal Tumor Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A method for diagnosing gastrointestinal Stromal Tumor

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor Molecular Diagnostics.

The Gastrointestinal Stromal Tumor Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Stromal Tumor Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastrointestinal Stromal Tumor Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Gastrointestinal Stromal Tumor Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera, GeneChem
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market report?

Ans: The main players in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market are Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera, GeneChem

What are the Application segmentation covered in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market report?

Ans: The Applications covered in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market report?

Ans: The Types covered in the Gastrointestinal Stromal Tumor Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2020-2031)

2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Region

2.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Dynamics

2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Trends

2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers

2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges

2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue

3.1.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue

3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024

3.5 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics Head office and Area Served

3.6 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application

3.7 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Type

4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031)

5 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Application

5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)

6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)

6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)

7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)

7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)

9.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Yin Feng Gene

11.1.1 Yin Feng Gene Company Details

11.1.2 Yin Feng Gene Business Overview

11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.1.5 Yin Feng Gene Recent Development

11.2 KingMed

11.2.1 KingMed Company Details

11.2.2 KingMed Business Overview

11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.2.5 KingMed Recent Development

11.3 Geneis

11.3.1 Geneis Company Details

11.3.2 Geneis Business Overview

11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.3.5 Geneis Recent Development

11.4 Haplox

11.4.1 Haplox Company Details

11.4.2 Haplox Business Overview

11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.4.5 Haplox Recent Development

11.5 AmoyDX

11.5.1 AmoyDX Company Details

11.5.2 AmoyDX Business Overview

11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.5.5 AmoyDX Recent Development

11.6 Admera

11.6.1 Admera Company Details

11.6.2 Admera Business Overview

11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.6.5 Admera Recent Development

11.7 GeneChem

11.7.1 GeneChem Company Details

11.7.2 GeneChem Business Overview

11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction

11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

11.7.5 GeneChem Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Yin Feng Gene

KingMed

Geneis

Haplox

Amoydx

Admera

GeneChem

List of Tables

Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2025)

Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2026-2031)

Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends

Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers

Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges

Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints

Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)

Table 19. Ranking of Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application

Table 23. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Yin Feng Gene Company Details

Table 49. Yin Feng Gene Business Overview

Table 50. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 51. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Yin Feng Gene Recent Development

Table 53. KingMed Company Details

Table 54. KingMed Business Overview

Table 55. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 56. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 57. KingMed Recent Development

Table 58. Geneis Company Details

Table 59. Geneis Business Overview

Table 60. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 61. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Geneis Recent Development

Table 63. Haplox Company Details

Table 64. Haplox Business Overview

Table 65. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 66. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 67. Haplox Recent Development

Table 68. AmoyDX Company Details

Table 69. AmoyDX Business Overview

Table 70. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 71. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 72. AmoyDX Recent Development

Table 73. Admera Company Details

Table 74. Admera Business Overview

Table 75. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 76. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Admera Recent Development

Table 78. GeneChem Company Details

Table 79. GeneChem Business Overview

Table 80. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product

Table 81. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 82. GeneChem Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Picture

Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. PCR Features

Figure 5. FISH Features

Figure 6. DNA Sequencing Features

Figure 7. Gene Chip Features

Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Clinical Diagnosis Case Studies

Figure 11. Drug Screening Case Studies

Figure 12. Research Case Studies

Figure 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered

Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2024

Figure 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024

Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2031)

Figure 34. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 50. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 51. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 52. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 53. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 54. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 55. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastrointestinal Stromal Tumor GIST Drug Market Research Report 2024

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Global Liver Cancer Molecular Diagnostics Market Research Report 2024

Global Esophageal Cancer Molecular Diagnosis Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Gallbladder Cancer Market Research Report 2024

Global Molecular Diagnosis of Rectal Cancer Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Bladder Cancer Molecular Diagnostics Market Research Report 2024

Global Kidney Cancer Molecular Diagnostics Market Research Report 2024

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Laryngeal Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis in Esophageal Cancer Market Research Report 2024

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions